HAMMOND, Ind. — A forensic expert in northwest Indiana says it’s possible to find the source of a falling bullet that fatally struck a 13-year-old boy. Hammond police told the Post-Tribune that they believe Noah Inman was playing basketball on July 1 when he was struck by a bullet that was likely fired into the...
NYS Entity Status
NYS Filing Date
JUNE 09, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - DAVID D. HAMMOND, LLC
AROUND THE WEB
- Forensic experts search for source of falling bullet that killed teen
By Associated Press - Friday Jul 14, 2017
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- Teen critically hurt from falling bullet
By Jackie Salo - Tuesday Jul 4, 2017
An Indiana teen was in critical condition Monday after being hit in the head by a bullet shot into the air like a firework, authorities said. The 13-year-old boy was playing basketball with friends Saturday night in Hammond, just west of Gary, when he was struck in the head by a falling bullet and fell...
- Teen dies from fallen bullet while playing basketball
By Jackie Salo - Tuesday Jul 11, 2017
An Indiana teen has died after he was struck by a bullet reportedly shot into the sky like a firework. Noah Inman, 13, was playing basketball with friends July 1 in Hammond, just west of Gary, when he was hit in the head by a falling bullet and fell to the ground, according to news...
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]